Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Mark Hahn
Individual Investor

Mark Hahn

Overview

Edit Overview Section
Number of Portfolio Companies 1
Number of Exits 
Unlock for free
  • Investor Type 
    obfuscation
  • Number of Exits 
    obfuscation
Mark W. Hahn is based out of Raleigh, North Carolina and is the Independent Director and Audit Committee Member of Soleno Therapeutics. Mark previously worked at Verona Pharma as a Chief Financial Officer. Mark W. Hahn attended the University of Wisconsin, Milwaukee. Mark W. Hahn has been a Certified Public Accountant.

Personal Investments

Edit Personal Investments Section
Number of Investments 1
Mark Hahn invested in Verona Pharma on
obfuscation
. This investment - Post-IPO Equity - Verona Pharma - was valued at
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Verona Pharma Logo
Verona Pharma
—
Post-IPO Equity - Verona Pharma Logo
Post-IPO Equity - Verona Pharma
obfuscation

Exits

Edit Exits Section
Number of Exits 
Unlock for free
Mark Hahn has
obfuscation
exit - Verona Pharma. Mark Hahn has
obfuscation
exits. Their most notable exits are Verona Pharma.
  • Verona Pharma Logo
    Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

Jobs

Edit Jobs Section
Number of Past Jobs 2
Mark Hahn has had 2 past jobs including Executive Vice President and Chief Financial Officer at Cempra.
Organization Name  
Title At Company  
Start Date  
End Date  
Cempra Logo
Cempra
Executive Vice President and Chief Financial Officer2014Nov 2017
Verona Pharma Logo
Verona Pharma
Chief Financial OfficerMar 1, 2020—

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 2
Mark Hahn holds 2 board and advisor roles as Independent Director and Audit Committee Member at Soleno Therapeutics and Board of Directors at Opterion Health.

Education

Edit Education Section
Mark Hahn studied at University of Wisconsin, Milwaukee.

Recent News and Activity

Edit Recent News and Activity Section
Funding Round•Jul 17, 2020
Verona Pharma raised
obfuscation
from Abingworth and 21 other investors
Discover more funding rounds
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|